Treatment of fuchs endothelial dystrophy by descemet stripping without endothelial keratoplasty

Cornea

Volumn 35, Issue 10, 2016, Pages 1267-1273

  Borkar, Durga S ^a   Veldman, Peter ^a,b   Colby, Kathryn A ^a,b,c  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Descemet stripping; Endothelial cell repopulation; Fuchs endothelial dystrophy

Indexed keywords

ADULT; AGED; CASE STUDY; CATARACT; CELL COUNT; CLINICAL ARTICLE; CONFERENCE PAPER; CONFOCAL MICROSCOPY; CONGENITAL CORNEA DYSTROPHY; CONTROLLED STUDY; CORNEA EDEMA; CORNEAL PACHYMETRY; DESCEMET MEMBRANE; DESCEMET STRIPPING ENDOTHELIAL KERATOPLASTY; ENDOTHELIAL KERATOPLASTY; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; LENS IMPLANT; MALE; MEDICAL PRACTICE; MIDDLE AGED; PATIENT CODING; PHACOEMULSIFICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETINA DISEASE; RETROSPECTIVE STUDY; TREATMENT RESPONSE; UNITED STATES; VERY ELDERLY; VISION; VISUAL ACUITY; COMPLICATION; CORNEA ENDOTHELIUM; FUCHS' ENDOTHELIAL DYSTROPHY; LENS IMPLANTATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; REGENERATION;

AGED; AGED, 80 AND OVER; CATARACT; CELL COUNT; CORNEAL PACHYMETRY; DESCEMET MEMBRANE; DESCEMET STRIPPING ENDOTHELIAL KERATOPLASTY; ENDOTHELIUM, CORNEAL; FEMALE; FUCHS' ENDOTHELIAL DYSTROPHY; HUMANS; LENS IMPLANTATION, INTRAOCULAR; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; PHACOEMULSIFICATION; REGENERATION; RETROSPECTIVE STUDIES; VISUAL ACUITY;

EID: 84975157070     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0000000000000915     Document Type: Conference Paper

References (33)

1. Tong CM, Melles GR. Where is endothelial keratoplasty going: from Descemet stripping (automated) endothelial keratoplasty to Descemet membrane endothelial keratoplasty to Descemet membrane endothelial transfer? Can J Ophthalmol. 2012;47:197-200.
2. Eye Bank Association of America (EBAA). Surgical Use and Indications for Corneal Transplant Statistical Report Analysis-2014. EBAA, Washington, DC, 2015.
3. Lee WB, Jacobs DS, Musch DC, et al. Descemet's stripping endothelial keratoplasty: safety and outcomes: a report by the American Academy of Ophthalmology. Ophthalmology. 2009;116:1818-1830.
4. Allan BD, Terry MA, Price FW Jr, et al. Corneal transplant rejection rate and severity after endothelial keratoplasty. Cornea. 2007;26:1039-1042.
5. Anshu A, Price MO, Price FW Jr. Risk of corneal transplant rejection significantly reduced with Descemet's membrane endothelial keratoplasty. Ophthalmology. 2012;119:536-540.
6. Dirisamer M, Yeh RY, van Dijk K, et al. Recipient endothelium may relate to corneal clearance in Descemet membrane endothelial transfer. Am J Ophthalmol. 2012;154:290-296.e1.
7. Dirisamer M, Ham L, Dapena I, et al. Descemet membrane endothelial transfer: "free-floating" donor Descemet implantation as a potential alternative to "keratoplasty". Cornea. 2012;31:194-197.
8. Lam FC, Bruinsma M, Melles GR. Descemet membrane endothelial transfer. Curr Opin Ophthalmol. 2014;25:353-357.
9. Koenig SB. Long-term corneal clarity after spontaneous repair of an iatrogenic descemetorhexis in a patient with Fuchs dystrophy. Cornea. 2013;32:886-888.
10. Koizumi N, Okumura N, Ueno M, et al. Rho-associated kinase inhibitor eye drop treatment as a possible medical treatment for Fuchs corneal dystrophy. Cornea. 2013;32:1167-1170.
11. Shah RD, Randleman JB, Grossniklaus HE. Spontaneous corneal clearing after Descemet's stripping without endothelial replacement. Ophthalmology. 2012;119:256-260.
12. Moloney G, Chan UT, Hamilton A, et al. Descemetorhexis for Fuchs' dystrophy. Can J Ophthalmol. 2015;50:68-72.
13. Koenig SB. Planned descemetorhexis without endothelial keratoplasty in eyes with Fuchs corneal endothelial dystrophy. Cornea. 2015;34:1149-1151.
14. Ham L, Dapena I, Moutsouris K, et al. Persistent corneal edema after descemetorhexis without corneal graft implantation in a case of Fuchs endothelial dystrophy. Cornea. 2011;30:248-249.
15. Bleyen I, Saelens IE, van Dooren BT, et al. Spontaneous corneal clearing after Descemet's stripping. Ophthalmology. 2013;120:215.
16. Arbelaez JG, Price MO, Price FW Jr. Long-term follow-up and complications of stripping Descemet membrane without placement of graft in eyes with Fuchs endothelial dystrophy. Cornea. 2014;33:1295-1299.
17. Balachandran C, Ham L, Verschoor CA, et al. Spontaneous corneal clearance despite graft detachment in Descemet membrane endothelial keratoplasty. Am J Ophthalmol. 2009;148:227-234.e1.
18. Zafirakis P, Kymionis GD, Grentzelos MA, et al. Corneal graft detachment without corneal edema after Descemet stripping automated endothelial keratoplasty. Cornea. 2010;29:456-458.
19. Ziaei M, Barsam A, Mearza AA. Spontaneous corneal clearance despite graft removal in Descemet stripping endothelial keratoplasty in Fuchs endothelial dystrophy. Cornea. 2013;32:e164-e166.
20. Riazuddin SA, Parker DS, McGlumphy EJ, et al. Mutations in LOXHD1, a recessive-deafness locus, cause dominant late-onset Fuchs corneal dystrophy. Am J Hum Genet. 2012;90:533-539.
21. Riazuddin SA, Vithana EN, Seet LF, et al. Missense mutations in the sodium borate cotransporter SLC4A11 cause late-onset Fuchs corneal dystrophy. Hum Mutat. 2010;31:1261-1268.
22. Riazuddin SA, Zaghloul NA, Al-Saif A, et al. Missense mutations in TCF8 cause late-onset Fuchs corneal dystrophy and interact with FCD4 on chromosome 9p. Am J Hum Genet. 2010;86:45-53.
23. Mootha VV, Gong X, Ku HC, et al. Association and familial segregation of CTG18.1 trinucleotide repeat expansion of TCF4 gene in Fuchs' endothelial corneal dystrophy. Invest Ophthalmol Vis Sci. 2014;55:33-42.
24. Mootha VV, Hussain I, Cunnusamy K, et al. TCF4 triplet repeat expansion and nuclear RNA foci in Fuchs' endothelial corneal dystrophy. Invest Ophthalmol Vis Sci. 2015;56:2003-2011.
25. Wieben ED, Aleff RA, Tosakulwong N, et al. A common trinucleotide repeat expansion within the transcription factor 4 (TCF4, E2-2) gene predicts Fuchs corneal dystrophy. PLoS One. 2012;7:e49083.
26. Soliman AZ, Xing C, Radwan SH, et al. Correlation of severity of Fuchs endothelial corneal dystrophy with triplet repeat expansion in TCF4. JAMA Ophthalmol. 2015;133:1386-1391.
27. Zhang X, Igo RP Jr, Fondran J, et al; Fuchs' Genetics Multi-Center Study Group. Association of smoking and other risk factors with Fuchs' endothelial corneal dystrophy severity and corneal thickness. Invest Ophthalmol Vis Sci. 2013;54:5829-5835.
28. Jurkunas UV, Bitar MS, Funaki T, et al. Evidence of oxidative stress in the pathogenesis of Fuchs endothelial corneal dystrophy. Am J Pathol. 2010;177:2278-2289.
29. Su DH, Wong TY, Wong WL, et al; Singapore Malay Eye Study Group. Diabetes, hyperglycemia, and central corneal thickness: the Singapore Malay Eye Study. Ophthalmology. 2008;115:964-968.e1.
30. Zoega GM, Fujisawa A, Sasaki H, et al. Prevalence and risk factors for cornea guttata in the Reykjavik Eye Study. Ophthalmology. 2006;113: 565-569.
31. Joyce NC, Zhu CC. Human corneal endothelial cell proliferation: potential for use in regenerative medicine. Cornea. 2004;23(8 suppl): S8-S19.
32. He Z, Campolmi N, Gain P, et al. Revisited microanatomy of the corneal endothelial periphery: new evidence for continuous centripetal migration of endothelial cells in humans. Stem Cells. 2012;30:2523-2534.
33. Watanabe S, Oie Y, Fujimoto H, et al. Relationship between corneal guttae and quality of vision in patients with mild Fuchs' endothelial corneal dystrophy. Ophthalmology. 2015;122:2103-2109.